The California stem cell agency is spending $2.4 million a year on lawyers, a figure that one agency director has described as “awfully bloated.” More than one dollar out of every ten that CIRM spends on its operations goes for legal advice, and the subject came up at a meeting last month of a meeting [...]

The California stem cell agency is in the midst of making significant changes in its lending regulations, but says it is not part of an effort to transfer a $25 million loan to Geron to another company. That does not mean, however, that the agency is not going to transfer the loan at some point. CIRM [...]

A “special advisor” to the $3 billion California stem cell agency has been nominated to the board of directors of Sangamo BioSciences, Inc., a firm that is sharing in a $14.5 million grant from the state research enterprise. She is Saira Ramasastry, managing partner of Life Sciences Advisory, LLC, of Emerald Lake Hills, Ca., and [...]

6 Mid-Cap Biotechnology Stocks With Great Liquidity And Rated Buy Or BetterSeeking AlphaAre you interested in gaining exposure to biotechnology companies and companies with high liquidity? Do you prefer stocks that analysts rate as 'Buy', or better? If so, here are some ideas to start your stock search. The Current ratio is a liquidity … [...]

Herbicide Effects Extend Beyond PlantsAllAfrica.comBy Anne Outwater, 13 May 2012 HERBICIDE tolerant crops, developed through genetic engineering, were supposed to control weeds, and Bt crops were intended to control insect pests. In fact one of the most potent promises made around genetically … and more » Source:http://news.google.com/news?q=genetic-engineering&output=rss

ROCKVILLE, Md., May 9, 2012 /PRNewswire/ — Neuralstem, Inc. (CUR) today reported its financial results for the three months ended March 31, 2012 and provided a business and clinical update. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) “In the first Quarter of 2012, we entered the final cohort of our Phase I clinical trial in ALS at Emory University Hospital.

NEWARK, Calif., May 9, 2012 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM – News) today announced that Armin Curt, MD, FRCPC, Professor and Chairman, Spinal Cord Injury Center at the University of Zurich, and Medical Director of the Paraplegic Center at the Balgrist University Hospital and principal investigator for the Company’s Phase I/II clinical trial in chronic spinal cord injury, will provide a progress report on the trial on Thursday, May 17 at the Interdependence 2012 Global SCI Conference.

HAIFA, Israel, May 9, 2012 (GLOBE NEWSWIRE) — Pluristem Therapeutics, Inc.

Wed May 9, 2012 3:35pm BST (Reuters) – Pluristem Therapeutics Inc said a 7-year old girl suffering from a bone marrow disease experienced a reversal of her condition after receiving its experimental stem cell therapy, sending the Israeli company’s shares up 32 percent. The girl, suffering from aplastic bone marrow in which the patient has no blood-forming stem cells, had a significant rise in her red cells, white cells and platelets following an injection of Pluristem’s therapy — PLacental eXpanded cells. “The results of this unique case indicate that PLX cells may be effective in treating other diseases that affect the bone marrow,” Reuven Or, the child’s physician at Hadassah Medical Center, was quoted in a statement by Pluristem

By J. D. Heyes Have you ever read something so complex and confusing that it frustrated you to the point of distraction? Well, a new study has found that cancer trial literature causes that kind of frustration – and may be misleading to patients as well. According to Prof. Mary Dixon-Woods, professor of Medical Sociology [...]

For more than 20 years, the main choice for breast implants has been some form of silicone rubber. Recent cancer research suggests nanotechnology may make breast implants safer as an alternative to silicone. Approximately 75 percent of post-mastectomy patients choose some form of breast reconstruction. While no medical device is free of risks, silicone breast [...]

This is the main question that is lurking the minds of biologists for quite some time now because many possibilities for the occurrence of a homosexuality gene exist. During the 1990s many researcher were studying the topic but by the end of the 20th century all such research work was slowed down as many people [...]

The specialty drugs seem to be putting pressure on insurance premiums. These drugs which are being used for treating rare diseases is building pressure on the health insurance and is making it costly for everybody. In some of the cases the cost of the treatment can touch up to $200,000 a year. These drugs are [...]

Is anyway spirituality related to biotechnology? You don’t know the answer but a molecular biologist from Princeton University states that spiritual beliefs plays an important role in deciding whether people accept or reject biotechnology in the field of agriculture or medicine. Though some nations have accepted biotechnology but there are a number of those which [...]

Celebrex from Pfizer has received the approval from federal advisers for marketing it for children suffering from devastated form of arthritis even though there was a split opinion on this issue. Celebrex is a painkiller from the stable of Pfizer. Besides this a recommendation was also made for monitoring the effect of the dug for [...]

Two molecules occurring naturally in blood have been combined by researchers for engineering a molecular complex using solar energy for splitting water into oxygen and hydrogen. Energy is used from the sun for creating hydrogen gas which would serve as an alternative for electrolysis. This is an important development as it could also help in [...]

Researchers have found out that brain cells resulting from human embryonic stem cells resulted in the improvement of conditions of rats suffering from Parkinson but a problem was faced with regards to the eruption of brain tumor. After coming across this problem researchers are working to find a solution for it. This was found out [...]

The Star-Ledger – NJ.com Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal …MarketWatch (press release)GUANGZHOU, China, May 3, 2012 /PRNewswire via COMTEX/ — Johnson & Johnson (China) Investment Ltd. today announced it has acquired Guangzhou Bioseal Biotechnology Co., Ltd. (Bioseal) a privately held biopharmaceutical company specializing in the design …Johnson & Johnson buys Chinese [...]

Lixte Biotechnology Holdings Announces Submission of an IND to the FDA for …MarketWatch (press release)EAST SETAUKET, NY, May 1, 2012 /PRNewswire via COMTEX/ — John S. Kovach, MD, Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc. (LIXT.PK), announced the submission of an IND application to the Food and Drug Administration to … [...]

Biotechnology Booming In CharlottesvilleNBC 29 NewsSome business-minded folks in Charlottesville say there's a biotechnology boom happening in the city, one that could certainly bolster the bottom line for the economy in the area. Those familiar with the industry's growth say Charlottesville may not be … Source:http://news.google.com/news?q=biotechnology&output=rss